tirzepatide vs cagrisema tirzepatide: which next-generation weight loss treatment wins? CagriSema vs tirzepatide: which next-generation

Our take: GLP-1 microdosing is booming on social media trend and although weight loss drugmakers Novo and Lilly have neither studied nor endorsed mini doses, its another tactic for telehealth providers like Noom to stay in the weight loss game

Each purchase includes a complimentary bottle of 3ml bacteriostatic water

Conagra Brands is adding a "GLP-1 friendly" label to 26 select items in its Healthy Choice frozen food line

Weekly weight loss on semaglutide varies widely by individual, typically ranging from 0.5 to 2 pounds per week during active treatment phases

This is particularly true in the maintenance setting after patients achieve weight loss goals